An interventional study of Calcium Hydroxide (Ca(OH)2) and Mineral Trioxide Aggregate in Dental Pulp Capping and Dental Caries Extending to Pulp, sponsored by Jordan University of Science and Technology. Status unknown at 1 site in Jordan. Open to participants aged 12 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-09-25.
Sponsored by Jordan University of Science and Technology · Not applicable, Interventional, and Treatment
Calcium hydroxide and mineral trioxide aggregate have been used in vital pulp therapy with variable outcomes recorded by different study. They will be compared when used for direct pulp capping in cariously exposed mature permanent teeth.
Vital pulp therapy has the benefit of providing patients with a conservative treatment option with relatively low cost when compared to conventional root canal treatment and spares them possible post-treatment consequences that might occur. Vital pulp treatment in trauma cases is associated with high success rate but controversy still exists regarding vital pulp treatment in carious-exposed pulp.
The purpose of this study is to evaluate the success rate of direct pulp capping performed with MTA-Angelus® or calcium hydroxide in mechanical-exposed or carious-exposed mature permanent human teeth. Patients included in this study will be recruited from routine dental patients attending conservative clinics in JUST Dental Teaching Centre. Adult patients scheduled for routine conservative treatment involving caries removal and restoration with mechanical or carious pulp exposure will be invited to participate in this study.
A total of 80 carious human teeth with carious pulp exposure will be included in this randomized clinical study. Patients are among those scheduled for conservative dental treatment and end with pulp exposure. The patients and/or their parents will be asked to sign a consent form after receiving a detailed explanation about the study rationale, clinical procedures, and possible risks. The exposed teeth will be divided randomly into two experimental groups (n=40) according to the dressing materials; MTA-Angelus® or calcium hydroxide, then teeth will be restored with permanent filling. Teeth will be reviewed recording any signs and symptoms. Patients will be reviewed in 1 week, 3 months and yearly after. MTA-Angelus and calcium hydroxide are anticipated to be biocompatible and induce hard tissue barrier. This project will reveal if tested materials are presented with promising profile upon using as direct pulp capping dressing in mechanical and carious-exposed pulp.
Exclusion Criteria:
calcium hydroxide (Ca(OH)2 direct pulp capping will be performed in this group
Drug: Calcium Hydroxide (Ca(OH)2)
Mineral Trioxide Aggregate (MTA) direct pulp capping will be performed in this group
Drug: Mineral Trioxide Aggregate
Ca(OH)2 will be used in this group
Also known as: Ca(OH)2
MTA will be used in this group
Also known as: MTA
clinical vital pulp therapy success
Treatment was considered successful based on the absence of symptoms and signs Treatment was considered successful based on absence of symptoms and signs
Time frame: from date of randomization until failure reported for up to 100 months
Radiographic success
treatment could be further evaluated based on the absence of canal oblitration
Time frame: from date of randomization until failure reported for up to 100 months
Plan to share: Undecided
No publications or documents are linked to this record.
This study is status unknown, as verified in Sep 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Jordan University of Science and Technology